Krystal Biotech KRYS
NASDAQ KRYS
$322.28 -3.03 (-0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Krystal Biotech (KRYS) Return on Capital Employed [ROCE] (2017 - 2026)

Updated

Krystal Biotech's Return on Capital Employed [ROCE] came in at 14.97% for Q2 2026, up 1.28 percentage points from 13.68% a year earlier and up 0.75 percentage points from the prior quarter.

Analysis

Krystal Biotech (KRYS) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends

For FY2025, Krystal Biotech's Return on Capital Employed [ROCE] was 14.77%, up 6.90 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has increased in each of the last three years, with a five-year change of +28.27 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was 7.87% in FY2024 (+24.60 pp), -16.73% in FY2023 (+9.04 pp), -25.77% in FY2022 (-10.35 pp) and -15.42% in FY2021 (-1.92 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2017.
  • Year-over-year, Return on Capital Employed [ROCE] has increased for 12 consecutive quarters, with an average year-over-year change of +12.92 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2024 (a gain of 24.01 percentage points), and the weakest in Q4 2022 (a drop of 13.65 percentage points).
  • Business Quant data shows KRYS's Return on Capital Employed [ROCE] at 14.21% (Q1 2026), 13.62% (Q4 2025) and 14.43% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Krystal Biotech 9.54 Bn 6.31 Bn 112.79 Mn 14.97%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.97%
Mar 31, 2026 14.21%
Dec 31, 2025 13.62%
Sep 30, 2025 14.43%
Jun 30, 2025 13.68%
Mar 31, 2025 11.02%
Dec 31, 2024 7.17%
Sep 30, 2024 3.21%
Jun 30, 2024 -2.56%
Mar 31, 2024 -8.56%
Dec 31, 2023 -14.21%
Sep 30, 2023 -20.81%
Jun 30, 2023 -26.21%
Mar 31, 2023 -28.19%
Dec 31, 2022 -26.96%
Sep 30, 2022 -23.59%
Jun 30, 2022 -20.27%
Mar 31, 2022 -18.56%
Dec 31, 2021 -13.31%
Sep 30, 2021 -13.81%
API Access

Krystal Biotech Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KRYS&period=max&api_key=YOUR_API_KEY